PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY

Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently publis...

Full description

Bibliographic Details
Main Authors: S. A. Boytsov, I. P. Kolos
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:https://www.rpcardio.com/jour/article/view/1141
id doaj-75b89d21963742ceabdbf22b40457612
record_format Article
spelling doaj-75b89d21963742ceabdbf22b404576122021-09-03T13:15:24ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532016-01-0144697510.20996/1819-6446-2008-4-4-69-751140PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPYS. A. Boytsov0I. P. Kolos1Russian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaRussian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaAngiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT.https://www.rpcardio.com/jour/article/view/1141angiotensin ii receptor antagonistsace inhibitorsarterial hypertensionmyocardial infarctionatrial fibrillation
collection DOAJ
language English
format Article
sources DOAJ
author S. A. Boytsov
I. P. Kolos
spellingShingle S. A. Boytsov
I. P. Kolos
PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
Racionalʹnaâ Farmakoterapiâ v Kardiologii
angiotensin ii receptor antagonists
ace inhibitors
arterial hypertension
myocardial infarction
atrial fibrillation
author_facet S. A. Boytsov
I. P. Kolos
author_sort S. A. Boytsov
title PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_short PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_full PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_fullStr PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_full_unstemmed PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
title_sort place of angiotensin ii receptor antagonists in arterial hypertension therapy
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2016-01-01
description Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT.
topic angiotensin ii receptor antagonists
ace inhibitors
arterial hypertension
myocardial infarction
atrial fibrillation
url https://www.rpcardio.com/jour/article/view/1141
work_keys_str_mv AT saboytsov placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy
AT ipkolos placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy
_version_ 1717816650077569024